← Evidence map

ReviewCancer2019

Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials.

Joanne M Jeter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

18 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 30281145